Manmeet Ahluwalia, MD, Oncology, Cleveland, OH, Cleveland Clinic

ManmeetSinghAhluwaliaMD

Oncology Cleveland, OH

Hematologic Oncology, Neuro-Oncology

Cleveland Clinic

Dr. Ahluwalia is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ahluwalia's full profile

Already have an account?

Education & Training

  • University at Buffalo
    University at BuffaloFellowship, Hematology, 2008 - 2009
  • University at Buffalo
    University at BuffaloFellowship, Medical Oncology, 2006 - 2007
  • Fairview General HospitalResidency, Internal Medicine, 2003 - 2006
  • Maulana Azad Medical College
    Maulana Azad Medical CollegeClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - 2023
  • TX State Medical License
    TX State Medical License 2009 - Present
  • OH State Medical License
    OH State Medical License 2003 - 2023
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Upfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched ...  
    Cosette Dechant, Gene H Barnett, Andreas Seas, Eric C Leuthardt, Kevin O Juarez, Hanna Kemeny, Peter E Fecci, Manmeet S Ahluwalia, Mayur Sharma, Thomas L Beaumont, Alb..., Neurosurgery
  • Expression of LC3B and FIP200/Atg17 in Brain Metastases of Breast Cancer  
    Manmeet S Ahluwalia, Lingling Du, Adam Lauko, Robert J Weil, Samuel T Chao, Journal of Neuro-Oncology
  • Chapter 11 - Systemic Therapy for Brain Metastases  
    Manmeet Ahluwalia, MD, ScienceDirect

Lectures

  • SurVaxM with standard therapy in newly diagnosed glioblastoma: Phase II trial update. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Effect of therapeutic pressure on stability of EGFR amplification in glioblastoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Join now to see all

Authored Content

  • First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018
  • First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1 RelatedApril 2018

Press Mentions

  • What Are the Actual Warning Signs of a Brain Tumor?
    What Are the Actual Warning Signs of a Brain Tumor?February 27th, 2020
  • Experimental Glioblastoma Vaccine Shows Promise in Slowing Brain Tumor Growth
    Experimental Glioblastoma Vaccine Shows Promise in Slowing Brain Tumor GrowthJune 17th, 2019
  • Phase II Trial Shows Favorable Response for Patients Receiving Combination Therapy with SurVaxM
    Phase II Trial Shows Favorable Response for Patients Receiving Combination Therapy with SurVaxMJune 3rd, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations